TY - JOUR
T1 - Antifibrinolytic therapy for preventing oral bleeding in patients with a hemophilia or Von Willebrand disease undergoing oral or dental procedures
AU - van Galen, Karin P.M.
AU - Engelen, Eveline T.
AU - Mauser-Bunschoten, Evelien P.
AU - van Es, Robert J.J.
AU - Schutgens, Roger E.G.
PY - 2014/12/5
Y1 - 2014/12/5
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: Primarily, we aim to assess the efficacy of antifibrinolytic agents to prevent bleeding complications in people with hemophilia or VWD undergoing oral surgery. Secondary objectives are to assess if antifibrinolytic agents can replace or reduce the need for clotting factor concentrate therapy or desmopressin in people with hemophilia or VWD and further establish the effects of these agents on bleeding in oral surgery for each of these patient populations.
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: Primarily, we aim to assess the efficacy of antifibrinolytic agents to prevent bleeding complications in people with hemophilia or VWD undergoing oral surgery. Secondary objectives are to assess if antifibrinolytic agents can replace or reduce the need for clotting factor concentrate therapy or desmopressin in people with hemophilia or VWD and further establish the effects of these agents on bleeding in oral surgery for each of these patient populations.
UR - http://www.scopus.com/inward/record.url?scp=84973572469&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD011385
DO - 10.1002/14651858.CD011385
M3 - Article
AN - SCOPUS:84973572469
SN - 1469-493X
VL - 2014
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 12
M1 - CD011385
ER -